A clinical trial of comparing dexmedetomidine and remifentanil on the oximetry parameters in the patients with end-stage renal disease undergoing arteriovenous fistula formation
R. Dolatabadi, S. Motlagh, Mohamadreza Ghodraty, A. Shafeinia, A. Maleki, Z. Norouzi, Shiva Khaleghparast
{"title":"A clinical trial of comparing dexmedetomidine and remifentanil on the oximetry parameters in the patients with end-stage renal disease undergoing arteriovenous fistula formation","authors":"R. Dolatabadi, S. Motlagh, Mohamadreza Ghodraty, A. Shafeinia, A. Maleki, Z. Norouzi, Shiva Khaleghparast","doi":"10.4103/rcm.rcm_12_22","DOIUrl":null,"url":null,"abstract":"Background: Oximetry is a method for measuring the arterial hemoglobin saturation (SpO2) using pulse oximeter and is essential in any type of anesthetic procedures. The growing population of geriatrics in the recent decades in combination with an increase in the prevalence of chronic diseases including diabetes and hypertension are some of the leading causes for an increase in the prevalence of chronic kidney disease and end-stage renal disease (ESRD). The definite treatment for ESRD is renal transplant but unfortunately, it may take a long time to find a suitable kidney and continuing the patient's life may depend on dialysis. Arteriovenous fistula (AVF) formation is one of the first steps to prepare the patient for hemodialysis. ESRD itself is a reason for physical and psychosocial issues. Preparing a favorable condition for AVF surgery is essential to decrease the burden of the underlying disease. An efficient respiratory supply is necessary in all parts of an anesthetic procedures. Aims and Objectives: This study is a double-blind clinical trial to compare two anesthetic agents, dexmedetomidine and remifentanil in patients with ESRD who underwent AVF formation. Materials and Methods: SpO2 was measured on different phases including the time of initial incision, and after 10, 30, 60, 90, and 120 min of finishing the surgery. The data were analyzed using SPSS version 22, two-way repeated measures (ANOVA), and independent t-test. Results: This study showed that there was no any significant difference in using any of these two agents with regard to SpO2 in the different times of measurements during the anesthetic procedure and after the surgery in the recovery phase. Conclusion: This study showed that there is not any superiority in using DEX or REM in the patients undergo AVF formation. More studies on the other groups of the patients with different surgeries.","PeriodicalId":21031,"journal":{"name":"Research in Cardiovascular Medicine","volume":"11 1","pages":"66 - 70"},"PeriodicalIF":0.2000,"publicationDate":"2022-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Cardiovascular Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/rcm.rcm_12_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Oximetry is a method for measuring the arterial hemoglobin saturation (SpO2) using pulse oximeter and is essential in any type of anesthetic procedures. The growing population of geriatrics in the recent decades in combination with an increase in the prevalence of chronic diseases including diabetes and hypertension are some of the leading causes for an increase in the prevalence of chronic kidney disease and end-stage renal disease (ESRD). The definite treatment for ESRD is renal transplant but unfortunately, it may take a long time to find a suitable kidney and continuing the patient's life may depend on dialysis. Arteriovenous fistula (AVF) formation is one of the first steps to prepare the patient for hemodialysis. ESRD itself is a reason for physical and psychosocial issues. Preparing a favorable condition for AVF surgery is essential to decrease the burden of the underlying disease. An efficient respiratory supply is necessary in all parts of an anesthetic procedures. Aims and Objectives: This study is a double-blind clinical trial to compare two anesthetic agents, dexmedetomidine and remifentanil in patients with ESRD who underwent AVF formation. Materials and Methods: SpO2 was measured on different phases including the time of initial incision, and after 10, 30, 60, 90, and 120 min of finishing the surgery. The data were analyzed using SPSS version 22, two-way repeated measures (ANOVA), and independent t-test. Results: This study showed that there was no any significant difference in using any of these two agents with regard to SpO2 in the different times of measurements during the anesthetic procedure and after the surgery in the recovery phase. Conclusion: This study showed that there is not any superiority in using DEX or REM in the patients undergo AVF formation. More studies on the other groups of the patients with different surgeries.
背景:血氧仪是一种使用脉搏血氧仪测量动脉血红蛋白饱和度(SpO2)的方法,在任何类型的麻醉过程中都是必不可少的。近几十年来,老年人口的不断增长,加上慢性疾病(包括糖尿病和高血压)患病率的增加,是慢性肾病和终末期肾病(ESRD)患病率增加的一些主要原因。ESRD的明确治疗是肾脏移植,但不幸的是,可能需要很长时间才能找到合适的肾脏,并且患者的生命可能依赖于透析。动静脉瘘(AVF)的形成是准备患者进行血液透析的第一步。ESRD本身就是身体和社会心理问题的一个原因。为AVF手术准备一个有利的条件对于减少潜在疾病的负担至关重要。有效的呼吸供应在麻醉过程的所有环节都是必要的。目的和目的:本研究是一项双盲临床试验,比较右美托咪定和瑞芬太尼两种麻醉剂在发生AVF形成的ESRD患者中的作用。材料与方法:在初始切口时间及手术结束后10、30、60、90、120 min测定SpO2。数据分析采用SPSS version 22、双向重复测量(ANOVA)和独立t检验。结果:本研究显示,在麻醉过程中和手术后恢复期的不同测量时间,使用这两种药物的SpO2均无显著差异。结论:本研究表明,在AVF形成患者中使用DEX或REM没有任何优势。对其他组不同手术的患者进行了更多的研究。